Clario is a corporate services company based in the USA, specializing in the biotech and pharmaceuticals sectors. With a workforce of over 1,000 employees and reported revenue of approximately $350 million, Clario focuses on delivering solutions that enhance the effectiveness of clinical trials. The company has published a white paper that discusses within-session blood pressure variability (BPV) in clinical studies, highlighting the importance of accurate blood pressure measurement methodologies. This document outlines various measurement methods, including ambulatory blood pressure monitoring (ABPM), and emphasizes the significance of understanding BPV for assessing drug effects in long-term clinical trials. Clario's expertise in clinical trial support is reflected in its research initiatives, which aim to improve the accuracy and reliability of data collected during these trials. The company's contributions to the field underscore its commitment to advancing clinical research practices, particularly in relation to cardiovascular health assessments.